• 1
    Albores-Saavedra J, Delgado R, Henson, DE. Well-differentiated adenocarcinoma, gastric foveolar type, of the extrahepatic bile ducts: a previously unrecognized and distinctive morphologic variant of bile duct carcinoma. Ann Diagn Pathol 1999; 3: 7580.
  • 2
    Albores-Saavedra J, Henson DE, Klimstra D. Tumors of the gallbladder, extrahepatic bile ducts and ampulla of Vater. Fascicle 24. Washington, DC: Armed Forces Institute of Pathology, 2000.
  • 3
    Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the extrahepatic bile ducts. Histologic types, stage of disease and survival rates. Cancer 1992;70: 1498501.
  • 4
    Wistuba I, Gazdar AF, Roa I, Albores-Saavedra. P53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 1996; 27: 3605.
  • 5
    Chung C, Bautista N, O'Connell TX. Prognosis and treatment of bile duct carcinoma. Am Surg 1998; 64: 9215.
  • 6
    Nagorney DM, Donohue JH, Farnell MB, Schleck CD, Ilstrup DM. Outcomes after curative resections of cholangiocarcinoma. Arch Surg 1993; 128: 8719.
  • 7
    Teh M, Wee A, Raju GC. An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer 1994; 74: 15425.
  • 8
    Sturm PDJ, Hruban RH, Ramsoekh TB, Noorduyn LA, Tytgat GN, Gouma DJ, et al. The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region. J Pathol 1998; 186: 24753.
  • 9
    Washington K, Gottfried MR. Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver 1996; 16: 99104.
  • 10
    Rijken AM, Van Gulik TM, Polak MM, Sturm PDJ, Gouma DJ, Offerhaus GJA. Diagnostic prognostic value of incidence of K-ras codon 12 mutations in resected distal bile duct carcinoma. J Surg Oncol 1998; 68: 18792.
  • 11
    Watanabe M, Asaka M, Tanaka E, Kurosawa M, Kasai M, Miyazaki T. Point mutation of K-ras gene codon 12 in biliary tract tumors. Gastroenterology 1994; 107: 114753.
  • 12
    Imai M, Hoshi T, Ogawa K. K-ras codon 12 mutations in biliary tract tumors detected by polymerase chain reaction denaturing gradient gel electrophoresis. Cancer 1994; 73: 2727– 33.
  • 13
    Matsubara T, Sakurai Y, Sasayama Y, Hori H, Ochiai M, Funabiki T, et al. K-ras point mutations in cancerous and noncancerous biliary epithelium in patients with pancreaticobiliary maljunction. Cancer 1996; 77: 17527.
  • 14
    Hubens G, Delvauz G, Willems G, Bourgain C, Klöppel G. Papillomatosis of the intra- and extrahepatic bile ducts. Hepatogastroenterol 1991; 38: 4138.
  • 15
    Cheng MS, Ahchong AK, Mak KL Chun Yip AW. Case report. Two cases of biliary papillomatosis with unusual associations. J Gastroenterol Hepatol 1999; 14: 4647.
  • 16
    Albores-Saavedra J, Defortuna SM, Smothermon WE. Primary hyperplasia of the gallbladder and cystic and common bile ducts. Hum Pathol 1990; 21: 22831.
  • 17
    Sessa F, Solcia E, Capella C, Bonato M, Scarpa A, Zamboni G, et al. Intraductal papillary- mucinous tumors represent a distinct group of pancreatic neoplasms: an investigation of tumor cell differentiation and K-ras, p53 and C-erb-B-2 abnormalities in 26 patients. Virchows Arch 1994; 425: 35767.
  • 18
    Albores-Saavedra J, Henson DE, Milchgrub S. Intraductal papillary carcinoma of the main pancreatic duct. Int J Pancreatol 1994; 16: 2234.
  • 19
    Ogura Y, Takahashi K, Tabata M, Mizumoto R. Clinicopathological study on carcinoma of the extrahepatic bile-duct with special focus on cancer invasion on the surgical margins. World J Surg 1994; 18: 77884.
  • 20
    Kurosaki I, Tsukada K, Watanabe H, Hatakeyama K. Prognostic determinants in extrahepatic bile duct cancer. Hepatogastroenterol 1998; 45: 9059.